Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. - Wikidata - awgldk - TriplyDB

Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.

Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.

http://www.wikidata.org/entity/Q33531335

about

Translational metabolomics in cancer research Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review Metabolomic Identification in Cerebrospinal Fluid of the Effects of High Dietary Cholesterol in a Rabbit Model of Alzheimer's Disease Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.Reduction of novel circulating long-chain fatty acids in colorectal cancer patients is independent of tumor burden and correlates with age.Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma.The blood exposome and its role in discovering causes of disease.A "crossomics" study analysing variability of different components in peripheral blood of healthy caucasoid individuals.Metabolomics for biomarker discovery in gastroenterological cancer.A novel serum metabolomics-based diagnostic approach for colorectal cancer Serum amino acid profiles and their alterations in colorectal cancer.The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling.Metabolic system alterations in pancreatic cancer patient serum: potential for early detection.Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens.Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study Modeling cancer metabolism on a genome scale.Metabolomic applications to decipher gut microbial metabolic influence in health and disease Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.Metabolic profiling, a noninvasive approach for the detection of experimental colorectal neoplasia Exploring Metabolic Profile Differences between Colorectal Polyp Patients and Controls Using Seemingly Unrelated Regression.Biomarkers intersect with the exposome Biomarker Discovery and Translation in Metabolomics.Low-serum GTA-446 anti-inflammatory fatty acid levels as a new risk factor for colon cancer.Review of mass spectrometry-based metabolomics in cancer research.Colorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelled Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry.Metabolomics and detection of colorectal cancer in humans: a systematic review.Recent advances in metabolomics in oncology.Metabolomics for tumor marker discovery and identification based on chromatography-mass spectrometry.Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence.Direct infusion mass spectrometry for metabolomic phenotyping of diseases.Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective.Human serum-derived hydroxy long-chain fatty acids exhibit anti-inflammatory and anti-proliferative activity.Synthesis, NMR characterization and divergent biological actions of 2'-hydroxy-ceramide/dihydroceramide stereoisomers in MCF7 cells.Global and targeted serum metabolic profiling of colorectal cancer progression.Characterizing metabolic changes in human colorectal cancer.Metabolomics for the masses: The future of metabolomics in a personalized world.Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare).

P2860

Q26998663-880EACEE-0776-4532-87B9-7578B19E4511 Q30234900-CBF15591-A65D-41B7-8DA6-37D82622F78A Q33631144-4EDAF56A-E91A-470E-A4AA-11AF7369D67C Q33707386-7EE8E010-794C-460E-87E7-2FB937B53C06 Q33745104-8EE731B2-1448-4B5E-AC34-ADCA4DB5924B Q33757924-151D0914-8727-44FC-9547-5653B23726F5 Q33846310-ED9212F6-42DE-402B-A03C-56FAC1DDF50C Q34007629-4B691D6A-A48A-4C38-BCC9-5B8174D34A22 Q34130312-025F9A0C-8C75-43FA-9830-6C8E90198207 Q34318206-D3C71963-870D-4AB5-9719-BF9197F30A8E Q34336333-DF9FA150-E0AD-4BCB-BB0E-70DBAA434D39 Q34660782-6A2581FD-4C84-4596-9F5F-B9FC49F537AD Q34860197-989CE484-D444-4966-AE2C-B4ECDB861886 Q34984999-DFB767FC-923A-4ABE-8906-7CD6D33CF5E6 Q35042544-2AB98FCE-236D-4F66-B45A-BB915E94B7BB Q35595617-66F9A98D-6971-4468-A862-6D1C6EB44EF4 Q35756786-B483555E-2C1F-4315-8EBD-B8086234622F Q35850350-2F37B2F7-582A-49C4-B3FA-9E799B9E9BE1 Q35914935-DF4423C4-AF22-4528-B906-BD976CF4E9D2 Q36364067-F34406A6-CC4C-4CFD-A25B-1188800FD441 Q36456751-7779AACC-0775-4B33-AD52-2E73BBCE7D73 Q36509316-41801B8D-6B69-481A-B8D4-1E63DCB4E5A1 Q36607005-A4395ED1-7A3C-4ED6-85AB-842C74C1B034 Q36845593-ED433781-AB76-435D-B28A-AC3AE885BA86 Q36910237-841CE5D4-9752-4507-A289-D789BF0D33F6 Q37550758-30D6B018-C953-481C-B8E0-924DF6ADFC0D Q37578725-EA449036-EEE9-4605-B040-E39EAB8FECFB Q37725582-EDA6A2A7-1D51-49D1-8D66-3495323C56A2 Q37797462-88B841F1-0AFE-4EAB-A3F1-B3CBBCBBEAFA Q37990967-2F90DF4D-6921-43AA-9DDF-45763EDC595E Q38103592-F87310B1-B7B7-474E-9175-7225548FE342 Q38838580-D34CB928-EE95-4418-BBAC-2668006B3C60 Q39030360-CE98421A-F83F-4B9A-AE4C-81CCA872A325 Q39381552-941885BF-C1A4-4A84-B77D-34CF4398EDBF Q39541011-1187E89E-0DCE-4FC2-AFEB-98EF0B8AF8C2 Q39654212-9B8069C0-7947-449D-8EC1-62C639BFDA96 Q40149592-881DFC1C-0B64-4CCC-8BE3-635CD135E445 Q40974589-266E837C-6644-4EA0-A598-3BF365F2DB2E Q44951888-2CFB52B1-1AFE-4839-877F-87FED1B0F92E Q46237342-5A022C3B-BBBE-4A1B-B1E8-472E6CE63C37

P2860

Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.

http://www.wikidata.org/entity/Q33531335

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Reduced levels of hydroxylated ...... early screening and detection.

@ast

Reduced levels of hydroxylated ...... early screening and detection.

@en

Reduced levels of hydroxylated ...... early screening and detection.

@nl

type

label

Reduced levels of hydroxylated ...... early screening and detection.

@ast

Reduced levels of hydroxylated ...... early screening and detection.

@en

Reduced levels of hydroxylated ...... early screening and detection.

@nl

prefLabel

Reduced levels of hydroxylated ...... early screening and detection.

@ast

Reduced levels of hydroxylated ...... early screening and detection.

@en

Reduced levels of hydroxylated ...... early screening and detection.

@nl

P1433

Q33531335-01AA5D79-8D10-4592-8128-B7A1A22FAFDF

P1476

Q33531335-09832A00-794E-4FC2-9971-CB2067473762

P2093

Q33531335-15538CA0-73E2-412A-92B3-52B26C00B97C

Q33531335-182EDB96-5672-47D7-A9CE-5271FD4D6A2A

Q33531335-343A1998-42A5-4BF3-92E4-749B1EB357F1

Q33531335-3977E5B2-D2B0-4414-9FF6-4CFF40FA7AE5

Q33531335-3D5AE8BB-958F-4292-9909-4DA79740E9E0

Q33531335-455CE04F-1781-46EA-A1CC-7CF0FEA9C8BE

Q33531335-508E491D-7EEA-409B-9236-81A341A3C447

Q33531335-701B6684-8CA2-4D60-85AD-44CD438D653F

Q33531335-7357F1EC-9118-4E3C-8A08-4E177FFCD597

Q33531335-7B255D59-2338-403C-B417-04D371B74D33

P2860

Q33531335-003947BB-BAA9-4ABD-B9EF-A6C727A8AAD3

Q33531335-0BE5C042-7EF1-43E6-B750-9632F979269F

Q33531335-1411E143-A6ED-425F-83F3-A6E4930F3E1A

Q33531335-160D9847-2C1F-469D-8100-73853F1C018B

Q33531335-165C7F9A-4263-43C3-89D9-1705D09DC88B

Q33531335-1813A7B3-C32A-4045-8601-D1A16485F763

Q33531335-1CFA9B4E-D5BB-4FF0-8B39-2FB6D6CF6805

Q33531335-1FED9EDA-4F97-4301-8AA2-A732FD7E4FDE

Q33531335-25BC6251-8902-4E56-9A1D-032C3BA4C6F6

Q33531335-2794AA3D-E44A-41B1-A6BD-270E8F5BDF7F

P2888

Q33531335-233AEA1D-46A6-467E-BE29-01D9671AAD4A

P304

Q33531335-8F5200F6-9FFE-46EA-A04F-2BD543F51BF3

P31

Q33531335-2C3E62B3-A312-42EA-8DA2-73C14467DAF4

P356

Q33531335-899DB6F5-794B-4575-B42F-5F9E8630A420

P407

Q33531335-7A01C5AF-1CD7-4C88-BDF5-9BD14C555B90

P478

Q33531335-5E26B7FA-AFD0-4EFC-B6A1-A4A58CA3BBDD

P50

Q33531335-E7FC1B56-5DA2-428B-A261-AB38217CD625

P577

Q33531335-90EF519D-092C-4344-8D92-26DDC09A841A

P5875

Q33531335-CCBC0E6D-CAC5-45CE-8D19-5CE145799DE3

P6179

Q33531335-5C42467E-26B1-421E-8F69-209D8FBD366C

P698

Q33531335-9AA19A9C-EAB4-4E24-88C1-7F69BBC33E69

P921

Q33531335-36AAFEA2-A66A-4BF0-A222-2BD2FAC167E2

Q33531335-CAF6AEC5-2ABC-4342-951B-89AD21CF18D7

Q33531335-D544BDF7-E3D6-4789-80A9-C3C2E2EF5F8C

P932

Q33531335-6E748B72-9C8A-4391-A1D6-563A0F7A149C

P356

P1433

P1476

Reduced levels of hydroxylated ...... early screening and detection.

@en

P2093

Amin M Khan

http://www.w3.org/2001/XMLSchema#string

Amir Kavianpour

http://www.w3.org/2001/XMLSchema#string

Dayan B Goodenowe

http://www.w3.org/2001/XMLSchema#string

Doug Heath

http://www.w3.org/2001/XMLSchema#string

Dushmanthi Jayasinghe

http://www.w3.org/2001/XMLSchema#string

Fumio Nomura

http://www.w3.org/2001/XMLSchema#string

Hisahiro Matsubara

http://www.w3.org/2001/XMLSchema#string

Ichiro Takemasa

http://www.w3.org/2001/XMLSchema#string

Jun Liu

http://www.w3.org/2001/XMLSchema#string

Kevin Krenitsky

http://www.w3.org/2001/XMLSchema#string

P2860

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo

Novel chemical mediators in the resolution of inflammation: resolvins and protectins

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

Lipoxins and new lipid mediators in the resolution of inflammation

Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice

Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia.

Analyzing array data using supervised methods.

P2888

P304

13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1741-7015-8-13

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Mohammad Hossain

P577

2010-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41434777

http://www.w3.org/2001/XMLSchema#string

P6179

1010330938

http://www.w3.org/2001/XMLSchema#string

P698

20156336

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

2833138

http://www.w3.org/2001/XMLSchema#string